RSS   Newsletter   Contact   Advertise with us

Japan approves remdesivir for coronavirus treatment

Christian Fernsby ▼ | May 8, 2020
The Japanese government approved Thursday the use of the anti-viral drug remdesivir for novel coronavirus patients in an expedited review as Japan, like other countries, scrambles to contain coronavirus with the death toll gradually rising.
Approval   Remdesivir
The government fast-tracked its approval of remdesivir just three days after the Japanese unit of U.S. developer Gilead Sciences Inc. filed an application, and one week after the United States authorized emergency use of the drug for COVID-19 patients.

Topics: Japan remdesivir coronavirus

Expectations have grown that the drug will help treat patients with severe symptoms, though there is concern over whether sufficient supplies can be secured. Some experts have voiced concern about remdesivir, saying there is little information about its safety and effectiveness.

Possible side effects of remdesivir, which is injected into a vein, include liver damage and nausea.

The anti-flu drug Avigan developed by a Fujifilm Holdings Corp. subsidiary is also expected to be approved later in the month for use to treat patients infected with the coronavirus.